clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Precision Medicine
News & Features
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Translational Research
Protein that Prevents Tau Clearance Linked to AD and Other Tau…
Topics
All
Precision Medicine
Translational Research
Molecular Dx
Informatics
Oncology
Patient Care
New Products
Translational Research
Precision Molecular Nabs Investment from ADDF for Development of More Effective…
Translational Research
Researchers Detail Mechanism for Clearing Misfolded Proteins at Root of Alzheimer’s…
Precision Medicine
Agendia Reports Positive Results in IMPACt Trial for Breast Cancer
Translational Research
Detailed Map of Breast Cancer Reveals the Effects of Mutations on…
Magazine
Magazine
Clinical OMICs Magazine Volume 7, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 5
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 4
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Multimedia
All
Webinars
eBooks
Precision Medicine
From Bench to Clinic—The Potential of New Sequencing Tools
Precision Medicine
Mainstreaming Precision Oncology
eBooks
Better Understanding of Post-Translation Modifications Driving Innovation
Webinars
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Molecular Dx
Sample Preparation
Sample Preparation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Sample Preparation
IDT, SOPHiA Genetics Broaden Partnership to Clinical-Grade Technologies
January 17, 2020
Sample Preparation
Missing Neural Progenitor Protein May Be Responsible for Autism Development
January 10, 2020
Sample Preparation
Epigenomic Packaging of Blood’s Cell-Free DNA Reveals Biological Age
December 31, 2018
Sample Preparation
Nobel in Chemistry Awarded for Directed Evolution of Enzymes and Antibodies
October 4, 2018
Sample Preparation
Algorithm Helps Find the Right Spot to Split a Protein for...
October 4, 2018
Sample Preparation
Tecan Expands Into NGS Reagents with NuGEN Technologies Acquisition
August 20, 2018
Sample Preparation
RUNX Proteins Integral to Efficient DNA Repair
August 16, 2018
Sample Preparation
Cancer-Linked Rearrangements Pepper Genome’s Regulatory Regions
July 11, 2018
Sample Preparation
Innovate UK Awarding Up to £5M to Develop Genomic Analysis Technologies
June 22, 2018
Sample Preparation
NanoString Partners with Five CROs to Advance Quantification Platform
April 30, 2018
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]](https://www.clinicalomics.com/wp-content/uploads/2019/01/585-218x150.jpeg "Agendia Reports Positive Results in IMPACt Trial for Breast Cancer")
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-218x150.jpeg "Protein that Prevents Tau Clearance Linked to AD and Other Tau Tangle Proteinopathies")
